肠道 EB 病毒相关淋巴组织增殖性疾病误诊为肠结核一例_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

宋洪俊 ¹ , 熊晓凤 ² , 吴妹清 ¹ , 胥巧玉 ¹ , 门新璐 ¹ ,  唐小燕 ²

1. ;
2. ;

Corresponding author：

唐小燕, Email: tangxiaoyan02@163.com

Keywords：

DOI：

10.7507/1671-6205.202006065

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 宋洪俊, 熊晓凤, 吴妹清, 胥巧玉, 门新璐, 唐小燕. 肠道 EB 病毒相关淋巴组织增殖性疾病误诊为肠结核一例. Chinese Journal of Respiratory and Critical Care Medicine, 2020, 19(4): 410-413. doi: 10.7507/1671-6205.202006065 Copy

1.	Kim HJ, Ko YH, Kim JE, et al. Epstein-Barr Virus-associated lymphoproliferative disorders: review and update on 2016 WHO Classification. J Pathol Transl Med, 2017, 51(4): 352-358.
2.	Kim WY, Montes-Mojarro IA, Fend F, et al. Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases. Front Pediatr, 2019, 7: 71.
3.	周小鸽, 张燕林, 谢建兰, 等. 对 EB 病毒相关淋巴组织增殖性疾病的理解和认识. 中华病理学杂志, 2016, 45(12): 817-821.
4.	Swerdlow SH, Campo E, Pileri SA, et al. The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms. Blood, 2016, 127(20): 2375-2390.
5.	Ohshima K, Kimura H, Yoshino T, et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int, 2008, 58(4): 209-217.
6.	陆晓茜, 高举. 慢性活动性 EBV 感染诊治进展. 中国小儿血液与肿瘤杂志, 2013, 18(5): 198-200, 213.
7.	Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood, 2012, 119(3): 673-686.
8.	Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis, 2003, 187(4): 527-533.
9.	Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood, 2001, 98(2): 280-286.
10.	张倩, 张红宇, 张文丽, 等. 成人 EB 病毒相关 T/NK 细胞淋巴组织增殖性疾病临床及实验特征. 中国实验血液学杂志, 2013, 21(4): 953-957.
11.	Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatr Blood Cancer, 2007, 48(2): 124-131.
12.	曾祥宗, 魏娜, 王旖旎, 等. 61 例 EBV 相关噬血细胞性淋巴组织细胞增多症患者的疗效及预后分析. 中华血液学杂志, 2015, 36(6): 507-510.
13.	卢根, 谢正德, 申昆玲, 等. 儿童 EB 病毒相关性噬血细胞淋巴组织细胞增生症的临床特征和预后危险因素分析. 中华儿科杂志, 2010, 48(2): 121-126.
14.	Ai J, Xie Z. Epstein-Barr virus-positive T/NK-cell lymphoproliferative diseases in Chinese Mainland. Front Pediatr, 2018, 6: 289.
15.	Jin YK, Xie ZD, Yang S, et al. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China. Chin Med J (Engl), 2010, 123(11): 1426-1430.

1. Kim HJ, Ko YH, Kim JE, et al. Epstein-Barr Virus-associated lymphoproliferative disorders: review and update on 2016 WHO Classification. J Pathol Transl Med, 2017, 51(4): 352-358.
2. Kim WY, Montes-Mojarro IA, Fend F, et al. Epstein-Barr virus-associated T and NK-cell lymphoproliferative diseases. Front Pediatr, 2019, 7: 71.
3. 周小鸽, 张燕林, 谢建兰, 等. 对 EB 病毒相关淋巴组织增殖性疾病的理解和认识. 中华病理学杂志, 2016, 45(12): 817-821.
4. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 Revision of the World Health Organization Classification of Lymphoid Neoplasms. Blood, 2016, 127(20): 2375-2390.
5. Ohshima K, Kimura H, Yoshino T, et al. Proposed categorization of pathological states of EBV-associated T/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int, 2008, 58(4): 209-217.
6. 陆晓茜, 高举. 慢性活动性 EBV 感染诊治进展. 中国小儿血液与肿瘤杂志, 2013, 18(5): 198-200, 213.
7. Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood, 2012, 119(3): 673-686.
8. Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis, 2003, 187(4): 527-533.
9. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood, 2001, 98(2): 280-286.
10. 张倩, 张红宇, 张文丽, 等. 成人 EB 病毒相关 T/NK 细胞淋巴组织增殖性疾病临床及实验特征. 中国实验血液学杂志, 2013, 21(4): 953-957.
11. Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatr Blood Cancer, 2007, 48(2): 124-131.
12. 曾祥宗, 魏娜, 王旖旎, 等. 61 例 EBV 相关噬血细胞性淋巴组织细胞增多症患者的疗效及预后分析. 中华血液学杂志, 2015, 36(6): 507-510.
13. 卢根, 谢正德, 申昆玲, 等. 儿童 EB 病毒相关性噬血细胞淋巴组织细胞增生症的临床特征和预后危险因素分析. 中华儿科杂志, 2010, 48(2): 121-126.
14. Ai J, Xie Z. Epstein-Barr virus-positive T/NK-cell lymphoproliferative diseases in Chinese Mainland. Front Pediatr, 2018, 6: 289.
15. Jin YK, Xie ZD, Yang S, et al. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a retrospective study of 78 pediatric cases in mainland of China. Chin Med J (Engl), 2010, 123(11): 1426-1430.

Previous Article
结节性硬化症一例
Next Article
莫西沙星在慢性阻塞性肺疾病急性加重期的应用进展

Chinese Journal of Respiratory and Critical Care Medicine

肠道 EB 病毒相关淋巴组织增殖性疾病误诊为肠结核一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content